UnknownPhase 3NCT05749666

Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis

Studying Takayasu arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese SLE Treatment And Research Group
Principal Investigator
Xinping Tian, MD
Peking Union Medical College Hospital
Intervention
Tofacitinib 5 MG(drug)
Enrollment
50 enrolled
Eligibility
18-65 years · All sexes
Timeline
20232025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05749666 on ClinicalTrials.gov

Other trials for Takayasu arteritis

Additional recruiting or active studies for the same condition.

See all trials for Takayasu arteritis

← Back to all trials